Effect of ciprofloxacin and levofloxacin on some oxidative stress parameters in brain regions of male albino rats

African Journal of Pharmacy and Pharmacology

Volumn 5, Issue 16, 2011, Pages 1888-1897

  Rawi, Sayed M ^a   Mourad, Iman M ^b   Arafa, Nadia M S ^c   Alazabi, Naema I ^d  

^a KING ABDULAZIZ UNIVERSITY   (Saudi Arabia)

^b CAIRO UNIVERSITY   (Egypt)

^c JAZAN UNIVERSITY   (Saudi Arabia)

^d UNIVERSITY OF ALGARVE   (Portugal)

Author keywords

Cerebral cortex; Ciprofloxacin; Hippocampus; Levofloxacin; Oxidative stress; Striatum

Indexed keywords

ADENOSINE TRIPHOSPHATASE; CIPROFLOXACIN; GLUTATHIONE; GLUTATHIONE PEROXIDASE; LEVOFLOXACIN; NITRIC OXIDE; POTASSIUM ION; SODIUM ION; SUPEROXIDE DISMUTASE;

ANATOMICAL VARIATION; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN CORTEX; BRAIN FUNCTION; CONTROLLED STUDY; CORPUS STRIATUM; DRUG EFFICACY; DRUG INHIBITION; ELECTROENCEPHALOGRAM; ENZYME ACTIVITY; HIPPOCAMPUS; LIPID PEROXIDATION; MALE; NONHUMAN; OXIDATIVE STRESS; RAT; REDOX STRESS; TREATMENT OUTCOME;

EID: 80655146471     PISSN: None     EISSN: 19960816     Source Type: Journal    
DOI: 10.5897/AJPP11.417     Document Type: Article

References (102)

1. Agbaht K, Bitik B, Piskinpasa S, Bayraktar M, Topeli A (2009). Ciprofloxacin-associated seizures in a patient with underlying thyrotoxicosis: case report and literature review. Int. Clin. Pharmacol. Ther., 47 (5): 303-310.
2. Akahane K, Kato M, Takayama S (1993). Involvement of Inhibitory and Excitatory Neurotransmitters in Levofloxacin-and Ciprofloxacin-Induced Convulsions in Mice. Antimicrob. Agents Chemother. 37(9): 1764-1770.
3. Akahane K, Ohkawara S, Nomura M, Kato M. (1996). Effect of bile duct ligation and unilateral nephrectomy on brain concentration and convulsant potential of the quinolone antibacterial agent levofloxacin in rats. Fundam. Appl. Toxico., 29: 280-286.
4. Akasaka T, Kurosaka S, Uchida Y, Tanaka M, Sato K, Hayakawa I (1998). Antibacterial activities and inhibitory effects of sitafloxacin (DU-6859a) and its optical isomers against type II topoisomerases. Antimicrob. Agents Chemother. 42: 1284-1287.
5. Albesa I, Becerra MC, Battan PC, Paez PL (2004). Oxidative stress involved in the antibacterial action of different antibiotics. Biochem. Biophys. Res. Commun. 317: 605-609.
6. Ang CW, Carlson GC, Coulter DA (2006). Massive and specific dysregulation of direct cortical input to the hippocampus in temporal lope epilepsy. J. Neurosci., 15, 26 (46): 11850-11856.
7. Aspinall SL, Good CB, Jiang R, McCarren M, Dong D, Cunningham FE (2009). Severe dysglycemia with the fluoroquinolones: a class effect? Clin. Infect. Dis. 49(3): 402-408.
8. Atkinson A, Gatenby AD, Lowe AG (1971). Subunit structure of Na+, K+-dependent transport AT Pase. Nat. New Biol. 233: 145-146.
9. Ball P (2003). Adverse drug reactions: implications for the development of fluoroquinolones. J. Antimicrob. Chemother., 51: 21-27.
10. Ball P, Mandell L, Niki Y, Tillotson G (1999). Comparative tolerability of the newer fluoroquinolone antibacterials. Drug Saf., 21: 407-421.
11. Becerra MC, Albesa I (2002). Oxidative stress induced by ciprofloxacin in Staphylococcus aureus. Biochem. Biophys. Res. Commun., 297: 1003-1007.
12. Becnel BL, Maynard MJ, Morgan-Linnell SK, Horton LB, Sucgang R, Hamill RJ, Jimenez JR, Versalovic J, Steffen D, Zechiedrich L (2009). Relationships among ciprofloxacin, gatifloxacin, levofloxacin, and norfloxacin MICs for fluoroquinolone-resistant Escherichia coli clinical isolates. Antimicrob. Agents Chemother., 53(1): 229-234.
13. Bellon A, Perez-Garcia G, Coverdale JH, Chacko RC (2009). Seizures associated with levofloxacin: case presentation and literature review. Eur. J. Clin. Pharmacol., 65 (10): 959-962.
14. Bergamini CM, Gambetti S, Dondi A, Cervellati C (2004). Oxygen, reactive oxygen species and tissue damage, Curr. Pharm. Des., 10(14): 1611-1626.
15. Bertino JJR, Fish D (2000). The safety profile of the fluoroquinolones. Clin. Ther., 22: 798-817.
16. Brummett R, Fox K (1989). Aminoglycoside-induced hearing loss in humans. Antimicrob. Agents Chemother., 33: 797-800.
17. Butler J, Hoey BM (1993). Redox cycling drugs and DNA damage. In: Halliwell B. Aruoma OI (eds) DNA and free radicals: Ellis Horwood Ltd., West Sussex, England, pp. 243-273.
18. Cabiscol E, Tamarit J, Ros J (2000). Oxidative stress in bacteria and protein damage by reactive oxygen species. Int. Microbiol., 3: 3-8.
19. Cadet JL, Brannock C (1998). Free radicals and the pathobiology of brain dopamine systems. Neurochem. Int., 32: 117-131.
20. Cao Q, Wei LR, Lu LL, Zhao CL, Zhao HY, Yang H (2007). Astrocytes protect MN9D neuronal cells against rotenone-induced oxidative stress by a glutathione-dependent mechanism. Sheng Li Xue Bao., 59 (3): 253-259.
21. Carrie AQ (2004). Possible Gatifloxacin-Induced Seizure. Ann. Pharmacother. 38 (2): 235-237.
22. Castora FJ, Vissering FF, Simpson MV (1983). The effects of bacterial DNA gyrase inhibitors on DNA synthesis in mammalian mitochondria. Biochim. Biophys. Acta, 740: 417-427.
23. Cavalheiro EA, Leite JP, Bortolotto ZA, Turski WA, Ikonomidou C, Turski L (1991). Long-term effects of pilocarpine in rats: structural damage of the brain triggers kindling and spontaneously recurrent seizures. Epilepsia, 32: 778-782.
24. Christakou A, Robbins TW, Everitt B (2004). Prefrontal cortical-ventral striatal interactions involved in affective modulation of attentional performance: implications for corticostriatal circuit function. J. Neurosci., 24: 773-780.
25. Circu ML, Aw TY (2008). Glutathione and apoptosis. Free Radic. Res., 42: 689-706.
26. Darwish T (2008). Ciprofloxacin-induced seizures in a healthy patient. NZ Med. J., 121 (1277):104-105.
27. Diaz-Hernandez JI, Almeida A, Delgado-Esteban M, Fernandez E, Bolanos JP (2005). Knockdown of glutamate-cysteine ligase by small hairpin RNA reveals that both catalytic and modulatory subunits are essential for the survival of primary neurons. J. Biol. Chem., 280: 38992-39001.
28. Dringen R, Hirrlinger J (2003). Glutathione pathways in the brain. Biol. Chem., 384: 505-516.
29. Drlica K, Malik M, Kerns RJ, Zhao X (2008). Quinolone-mediated bacterial death. Antimicrob. Agents Chemother., 52: 385-392.
30. Franco R, Bortner CD, Cidlowski JA (2006). Potential roles of electrogenic ion transport and plasma membrane depolarization in apoptosis. J. Membr. Biol., 209: 43-58.
31. Franco R, DeHaven WI, Sifre M, Bortner CD, Cidlowski JA (2007). Glutathione depletion and disruption of intracellular ionic homeostasis regulate lymphoid cell apoptosis. J. Biol. Chem., 283: 36071-36087.
32. Freitas RM, Vasconcelos SM, Souza FC, Viana GS, Fonteles MM (2005). Oxidative stress in the hippocampus after status epilepticus in rats. FEBS J. 272: 1307-1312.
33. Garber SM, Pound MW, Miller SM (2009). Hypoglycemia associated with the use of levofloxacin. Am. J. Health Syst. Pharm. 66 (11): 1014-1019.
34. Goswami M, Mangoli SH, Jawali N (2006). Involvement of reactive oxygen species in the action of ciprofloxacin against Escherichia coli. Antimicrob. Agents. Chemother., 50 (3): 949-954.
35. Gottlieb M, Leal-Campanario R, Campos-Esparza MR, Sánchez-Gómez MV, Alberdi E, Arranz A, Delgado-García JM, Gruart A, Matute C (2006). Neuroprotection by two polyphenols following excitotoxicity and experimental ischemia. Neurobiol Dis., 23(2): 374-386.
36. Guidance for Industry and Reviewers (2002). Estimating the safe starting dose in clinical trials for therapeutics in adult healthy volunteers. Food and Drug Administration, pp.1-26.
37. Gupta YK, Briyal S, Sharma M (2009). Protective effect of curcumin against kainic acid induced seizures and oxidative stress in rats. Ind. J. Physiol. Pharmacol., 53(1): 39-46.
38. Gürbay A, Hincal F (2004). Ciprofloxacin-induced glutathione redox status alterations in rat tissues. Drug Chem. Toxicol., 27(3): 233-242.
39. Gürbay A, Gonthier B, Signorini-Allibe N, Barret L, Favier A, Hincal F (2006). Ciprofloxacin-induced DNA damage in primary culture of rat astrocytes and protection by Vitamin E. Neurotoxicology, 27(1): 6-10.
40. Gürbay A, Gonthier B, Barret L, Favier A, Hincal F (2007). Cytotoxic effect of ciprofloxacin in primary culture of rat astrocytes and protection by Vitamin E. Toxicology, 229 (1-2): 54-61.
41. Halliwell B (1992). Reactive oxygen species and the central nervous system. J. Neurochem., 59:1609-1623.
42. Hasbun R, Quagliarello VI (1998). Use of quinolones in the treatment of bacterial meningitis, In The quinolones 2nd ed. Academic Press, Inc., New York, N. Y, pp 2877-301.
43. Hayashi M (2009). Oxidative stress in developmental brain disorders. Neuropathol., 29: 1-8.
44. Henderson GI, Chen JJ, Schenker S (1999). Ethanol, oxidative stress, reactive aldehydes, and the fetus. Frontiers in Bioscience: J. Virt. Lib., 4: 541-550.
45. Hyman BT, Van Hoesen GW, Damasio A (1990). Memory-related neural systems in Alzheimer's disease: an anatomic study. Neurology, 40: 1721-1730.
46. Jayatilleke E, Shaw S (1993). A high performance liquid chromatographic assay for reduced and oxidized glutathione in biological samples. Anal. Biochem., 214 (2): 452-457.
47. Jose J, Jimmy B, Saravu K (2007). Dysglycemia associated with the use of fluoroquinolones-focus on gatifloxacin. J. Clin. Diag. Res., (3): 185-187.
48. Karalas F, Karatepe M, Baysar A (2002). Determination of free malondialdehyde in human serum by high performance liquid chromatography. Anal. Biochem., 311: 76-79.
49. Kawahara S (1998). Chemotherapeutic agents under study. Nippon Rinsho. 56 (12): 3096-3099.
50. Kelly ME, Batty RA, McIntyre DC (1999). Cortical spreading depression reversibly disrupts convulsive motor seizure expression in amygdale kindled rats. Neurosci., 91: 305-313.
51. Kelly ME, Staines WA, McIntyre DC (2002). Secondary generalization of hippocampal kindled seizures in rats: examination of the periform cortex. Brain Res., 957(1): 152-161.
52. Kim J, Ohtani H, Tsujimoto M, Sawada Y (2009). Quantitative comparison of the convulsive activity of combination of twelve fluoroquinolones with five nonsteroidal anti-inflammatory agents. Drug Metab. Pharmacokin., 24(2): 167-174.
53. Kohanski MA, Dwyer DJ, Hayete B, Lawrence CA, Collins JJ (2007). A common mechanism of cellular death induced by bactericidal antibiotics. Cell, 130: 797-810.
54. Kohanski MA, Dwyer DJ, Collins JJ (2010). How antibiotics kill bacteria: from targets to networks. Nat. Rev. Microbiol., (8): 423-435.
55. Kourie JI (1998). Interaction of reactive oxygen species with ion transport mechanisms. Am. J. Physiol., 275: 1-24.
56. Koziel R, Zablocki K, Duszynski J (2006). Calcium signals are affected by ciprofloxacin as a consequence of reduction of mitochondrial DNA content in Jurkat cells. Antimicrob. Agents. Chemother., 50: 1664-1671.
57. Koziel R, Szczepanowska J, Magalska A, Piwocka K, Duszynski J, Zablocki K (2010). Ciprofloxacin inhibits proliferation and promotes generation of aneuploidy in Jurkat cells. J. Physiol. Pharmacol., 61(2): 233-239.
58. Lawrence JW, Darkin-Rattray S, Xie F, Neims AH, Rowe TC (1993). 4-Quinolones cause a selective loss of mitochondrial DNA from mouse L1210 leukemia cells. J. Cell Biochem., 51: 165-174.
59. Lawrence KR, Adra M, Keir C (2006). Hypoglycemia-induced anoxic brain injury possibly associated with levofloxacin. J. Infect., 52(6): 177-180.
60. Li Q, Peng S, Sheng Z, Wang Y (2010). Ofloxacin induces oxidative damage to joint chondrocytes of juvenile rabbits: excessive production of reactive oxygen species, lipid peroxidation and DNA damage. Eur. J. Pharmacol., 626 (2-3): 146-153.
61. Liu Q, Wang JC (1999). Similarity in the catalysis of DNA breakage and rejoining by type IA and IIA DNA topoisomerases. Proc. Natl. Acad. Sci. USA, 96: 881-886.
62. Liu H, Mulholland SG (2005). Appropriate antibiotic treatment of genitourinary infections in hospitalized patients. Am. J. Med., 118 (7A): 14S-20S.
63. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ (1951). Protein measurement with the Folin phenol reagent. J. Biol. Chem., 193(1): 265-275.
64. MacDougall C, Guglielmo BJ, Maselli J, Gonzales R (2005). Antimicrobial drug prescribing for pneumonia in ambulatory care. Emer. Infect. Dis., 11 (3): 380-384.
65. Machado FR, Ferreira AG, Da Cunha AA, Tagliari B, Mussulini BH, Wofchuk S, Wyse AT (2011). Homocysteine alters glutamate uptake and Na+, K+-ATPase activity and oxidative status in rats hippocampus: protection by vitamin C. Metab Brain Dis., 26(1): 61-67.
66. Maeda N, Tamagawa T, Niki I, Miura H, Ozawa K, Watanabe G, Nonogaki K, Uemura K, Iguchi A (1996). Increase in insulin release from rat pancreatic islets by quinolone antibiotics. Brit.J. pharmacol., 117:372-376.
67. Minami M, Yoshikawa H (1979). A simplified assay method of superoxide dismutase activity for clinical use. Clin. Chim. Acta, 92: 337-342.
68. Mingeot-Leclercq MP, Tulkens PM (1999). Aminoglycosides: nephrotoxicity. Antimicrob. Agents Chemother, 43: 1003-1012.
69. Moein S, Farzami B, Khaghani S, Moein MR, Larijani B (2007). Antioxidant properties and prevention of cell cytotoxicity of Phlomis persica Boiss. DARU. 15(2): 83-88.
70. Motomura M, Kataoka Y, Takeo G, Shibayama K, Ohishi K, Nakamura T, Niwa M, Tsujihata M, Nagataki S (1991). Hippocampus and frontal cortex are the potential mediatory sites for convulsions induced by new quinolones and non-steroidal anti-inflammatory drugs. Int. J. Clin. Pharmacol. Ther. Toxicol., 29(6): 223-227.
71. Müller M (2000). Microdialysis in clinical drug delivery studies. Adv. Drug Deliv. Rev., 45 (2-3): 255-269.
72. Munhoz CD, Kawamoto EM, de Sá Lima L, Lepsch LB, Glezer I, Marcourakis T, Scavone C (2005). Glutamate modulates sodiumpotassium-ATPase through cyclic GMP and cyclic GMP-dependent protein kinase in rat striatum. Cell Biochem. Funct., 23(2): 115-123.
73. Nelson JM, Chiller TM, Powers JH, Angulo FJ (2007). Fluoroquinoloneresistant Campylobacter species and the withdrawal of fluoroquinolones from use in poultry: a public health success story. Clin. Infect. Dis., 44 (7): 977-980.
74. Nilson P, Ronne-Engstrom E, Flink R, Ungerstedt U, Carlson H, Hillered L (1994). Epileptic seizure activity in the acute phase following cortical impact trauma in rat. Brain. Res., 637: 227-232.
75. Oliphant CM, Green GM (2002). Quinolones: a comprehensive review. Am. Fam. Physician, 65: 455-464.
76. Owens RC, Ambrose PG (2005). Antimicrobial safety: focus on fluoroquinolones. Clin. Infect. Dis., 41 (2): 144-157.
77. Papadoyannis LN, Samanidou VF, Nitsos CHC (1999). Simultaneous determination of nitrite and nitrate in drinking water and human serum by high performance anion-exchange chromatography and UV detection. J. Liquid Chromatogr. Relat. Technol., 22(13): 2023-2041.
78. Pervaiz S, Clement MV (2002). A permissive apoptotic environment: function of a decrease in intracellular superoxide anion and cytosolic acidification. Biochem. Biophys. Res. Commun., 290: 1145-1150.
79. Pomposiello PJ, Demple B (2000). Identification of SoxS-Regulated Genes in Salmonella enterica Serovar Typhimurium. Bacteriology, 182(1): 23-29.
80. Rajasekaran K (2005). Seizure-induced oxidative stress in rat brain regions: blockade by nNOS inhibition. Pharmacol. Biochem. Behav., 80(2): 263-272.
81. Rotruck JT, Pope AL, Ganther HE, Swanson AB, Hafeman DG, Hoekstra WG (1973). Selenium: Biochemical role as a component of glutathione peroxidase. Science, 179: 588-590.
82. Saito T, Nakamura M, Watari M, Isse K (2008). Tardive seizure and antibiotics: case reports and review of the literature. J. ECT, 24(4): 275-276.
83. Sawas AH, Gilbert JC (1984). Possible mechanism of inhibition by lipid peroxidation of ATPase activities of rat cerebral cortex synaptosomes. Arch. Int. Pharmacodyn. Ther., 269(1): 4-11.
84. Schmuck G, Schürmann A, Schlüter G (1998). Determination of the excitatory potencies of fluoroquinolones in the central nervous system by an in vitro model. Antimicrob. Agents Chemother., 42: 1831-1836.
85. Segev S, Yaniv I, Haverstock D, Reinhart H (1999). Safety of longterm therapy with ciprofloxacin: data analysis of controlled clinical trials and review. Clin. Infect. Dis., 28: 299-308.
86. Sen S, Jaiswal AK, Yanpallewar S, Acharya SB (2007). Aniogenic potential of ciprofloxacin and norfloxacin in rats. Sing. Med. J., 48(11): 1028-1032.
87. Shelat PB, Chalimoniuk M, Wang JH, Strosznajder JB, Lee JC, Sun AY, Simonyi A, Sun GY (2008). Amyloid beta peptide and NMDA induce ROS from NADPH oxidase and AA release from cytosolic phospholipase A2 in cortical neurons. J. Neurochem., 106: 45-55.
88. Shimizu T, Numata T, Okada Y (2004). A role of reactive oxygen species in apoptotic activation of volume-sensitive Cl-channel. Proc. Natl. Acad. Sci. USA. 101: 6770-6773.
89. Sies H (1991). Oxidative stress: from basic research to clinical application. Am. J. Med., 30; 91 (3C): 31S-38S.
90. Sies H (1999). Glutathione and its role in cellular functions. Free Radic. Biol. Med., 27(9-10): 916-921.
91. Sprandel KA, Rodvold KA (2003). Safety and tolerability of fluoroquinolones. Clin. Corn., (3): 29-36.
92. Sun AY, Chen YM (1998). Oxidative stress and neurodegenerative disorders. J. Biomed. Sci., 5: 401-414.
93. Tomita T, Onishi M, Sato E, Kimura Y, Kihira K (2007). Gatifloxacin induces augmented insulin release and intracellular insulin depletion of pancreatic islet cells. Biol. Pharm. Bull., 30 (4): 644-647.
94. Tsakiris S (2001). Effects of L-phenylalanine on acetylcholinesterase and Na+, K+-ATPase activities in adult and aged rat brain. Mech. Ageing Dev., 122:491-501.
95. Umezawa N, Arakane K, Ryu A, Mashiko S, Hirobe M, Nagano T (1997). Participation of reactive oxygen species in phototoxicity induced by quinolone antibacterial agents. Arch. Biochem. Biophys., 342: 275-281.
96. Ungerstedt U (1991). Microdialysis-Principles and applications for studies in animals and man. J. Intern. Med., 230(4): 365-373.
97. Vallurupalli S, Huesmann G, Gregory J, Jakoby IV (2008). Levofloxacinassociated hypoglycaemia complicated by pontine myelinolysis and quadriplegia. Dia. Med., 25: 856-859.
98. Voorn P, Vanderschuren LJ, Groenewegen HJ, Robbins TW, Pennartz CM (2004). Putting a spin on the dorsal-ventral divide of the striatum. Trends. Neurosci., 27: 468-474.
99. Wardman P, Candeias LP (1996). Fenton chemistry: an introduction. Radiat. Res., 145: 523-531.
100. Wieloch T (1985). Hypoglycemia-induced neuronal damage prevented by an N-methyl-D-aspartate antagonist. Science, 230: 681-683.
101. Winterbourn CC (1995). Toxicity of iron and hydrogen peroxide: the Fenton reaction. Toxicol. Lett., 82-83: 969-974.
102. Yin W, Cheng W, Shen W, Shu L, Zhao J, Zhang J (2007). Impairment of Na+, K+-ATPase in CD95(APO-1)-induced human Tcell leukemia cell apoptosis mediated by glutathione depletion and generation of hydrogen peroxide. Leukemia, 21: 1669-1678.